Biocartis Group NV Shs 144A/Reg S BCART
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.29
- Day Range
- €0.29–0.29
- 52-Week Range
- €0.29–0.63
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €27.24 Mil
- Volume/Avg
- 112,228 / 0
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.38
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 420
- Website
- https://www.biocartis.com
Valuation
|
Metric
|
BCART
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.38 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BCART
|
|---|---|
Quick Ratio | 1.49 |
Current Ratio | 2.15 |
Interest Coverage | −3.21 |
Quick Ratio
BCART
Profitability
|
Metric
|
BCART
|
|---|---|
Return on Assets (Normalized) | −60.36% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −54.98% |
Return on Assets
BCART
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Rqyfbmkshm | Trfc | $209.3 Bil | |
DHR
| Danaher Corp | Hknhqwzpcy | Crfpry | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Bstkkbd | Cjbpzj | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Chsykypgjc | Htdqsjt | $41.0 Bil | |
A
| Agilent Technologies Inc | Kgxkxygqxj | Jchf | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Srchxhhvcw | Pybffw | $26.4 Bil | |
ICLR
| Icon PLC | Ltwjswxj | Mwchky | $24.8 Bil | |
ILMN
| Illumina Inc | Jmkzfzfk | Jclrtt | $19.3 Bil | |
WAT
| Waters Corp | Ztmxrjrkt | Thck | $18.3 Bil | |
LH
| Laboratory Corp of America Holdings | Qmyvdkxs | Qhbxcy | $17.5 Bil |